HEADER RNA BINDING PROTEIN 18-AUG-23 8Q8G TITLE CRYSTAL STRUCTURE OF HSRNMT COMPLEXED WITH INHIBITOR DDD1870799 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MRNA CAP GUANINE-N7 METHYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: RG7MT1,MRNA (GUANINE-N(7))-METHYLTRANSFERASE,MRNA CAP COMPND 5 METHYLTRANSFERASE,HCMT1,HMET,HCM1P; COMPND 6 EC: 2.1.1.56; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RNMT, KIAA0398; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS METHYL TRANSFERASE, RNA BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.P.PETIT,P.K.FYFE REVDAT 1 28-AUG-24 8Q8G 0 JRNL AUTH A.P.PETIT,P.K.FYFE JRNL TITL STRUCTURE-GUIDED DESIGN OF HSRNMT INHIBITORS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.17 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 21172 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.860 REMARK 3 FREE R VALUE TEST SET COUNT : 1028 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.1700 - 4.5900 1.00 2958 126 0.1767 0.1917 REMARK 3 2 4.5900 - 3.6400 1.00 2856 160 0.1632 0.2305 REMARK 3 3 3.6400 - 3.1800 1.00 2887 147 0.1929 0.2650 REMARK 3 4 3.1800 - 2.8900 1.00 2851 150 0.2139 0.3178 REMARK 3 5 2.8900 - 2.6800 1.00 2876 149 0.2251 0.2821 REMARK 3 6 2.6800 - 2.5300 1.00 2859 155 0.2431 0.3425 REMARK 3 7 2.5300 - 2.4000 1.00 2857 141 0.2458 0.3417 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.353 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.776 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4648 REMARK 3 ANGLE : 1.012 6232 REMARK 3 CHIRALITY : 0.051 645 REMARK 3 PLANARITY : 0.008 779 REMARK 3 DIHEDRAL : 7.265 638 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8Q8G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-AUG-23. REMARK 100 THE DEPOSITION ID IS D_1292132812. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-SEP-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.3-6.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NA REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21196 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 42.170 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.15600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.85300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES PH 6.3-6.9, 50 MM NA2SO4, 18 REMARK 280 -25 % PEG 6000, PH 6.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.16800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 165 REMARK 465 GLN A 166 REMARK 465 GLY A 416 REMARK 465 LEU A 417 REMARK 465 SER B 165 REMARK 465 GLN B 166 REMARK 465 SER B 167 REMARK 465 ARG B 168 REMARK 465 ILE B 169 REMARK 465 ARG B 247 REMARK 465 ASP B 248 REMARK 465 SER B 249 REMARK 465 GLU B 250 REMARK 465 TYR B 251 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 193 CG CD OE1 NE2 REMARK 470 LYS A 196 CG CD CE NZ REMARK 470 TYR A 251 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU A 363 CG CD OE1 OE2 REMARK 470 LYS B 196 CG CD CE NZ REMARK 470 GLU B 363 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 253 152.40 -48.01 REMARK 500 LYS A 264 -41.15 -130.27 REMARK 500 ASN A 338 -158.23 -154.93 REMARK 500 TYR A 351 73.38 -119.85 REMARK 500 CYS A 356 89.75 -63.51 REMARK 500 GLU A 363 109.60 -25.99 REMARK 500 GLU B 334 35.51 -81.38 REMARK 500 ASN B 338 -159.50 -162.23 REMARK 500 VAL B 365 -64.74 -98.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LYS A 196 ARG A 197 -145.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5E8J RELATED DB: PDB REMARK 900 MRNA CAP GUANINE-N7 METHYLTRANSFERASE REMARK 900 RELATED ID: 8Q69 RELATED DB: PDB REMARK 900 MRNA CAP GUANINE-N7 METHYLTRANSFERASE IN COMPLEX WITH DDD1060606 DBREF 8Q8G A 165 415 UNP O43148 MCES_HUMAN 165 415 DBREF 8Q8G A 456 476 UNP O43148 MCES_HUMAN 456 476 DBREF 8Q8G B 165 415 UNP O43148 MCES_HUMAN 165 415 DBREF 8Q8G B 456 476 UNP O43148 MCES_HUMAN 456 476 SEQADV 8Q8G GLY A 416 UNP O43148 LINKER SEQADV 8Q8G LEU A 417 UNP O43148 LINKER SEQADV 8Q8G GLY A 418 UNP O43148 LINKER SEQADV 8Q8G CYS A 419 UNP O43148 LINKER SEQADV 8Q8G GLY B 416 UNP O43148 LINKER SEQADV 8Q8G LEU B 417 UNP O43148 LINKER SEQADV 8Q8G GLY B 418 UNP O43148 LINKER SEQADV 8Q8G CYS B 419 UNP O43148 LINKER SEQRES 1 A 276 SER GLN SER ARG ILE PHE TYR LEU ARG ASN PHE ASN ASN SEQRES 2 A 276 TRP MET LYS SER VAL LEU ILE GLY GLU PHE LEU GLU LYS SEQRES 3 A 276 VAL ARG GLN LYS LYS LYS ARG ASP ILE THR VAL LEU ASP SEQRES 4 A 276 LEU GLY CYS GLY LYS GLY GLY ASP LEU LEU LYS TRP LYS SEQRES 5 A 276 LYS GLY ARG ILE ASN LYS LEU VAL CYS THR ASP ILE ALA SEQRES 6 A 276 ASP VAL SER VAL LYS GLN CYS GLN GLN ARG TYR GLU ASP SEQRES 7 A 276 MET LYS ASN ARG ARG ASP SER GLU TYR ILE PHE SER ALA SEQRES 8 A 276 GLU PHE ILE THR ALA ASP SER SER LYS GLU LEU LEU ILE SEQRES 9 A 276 ASP LYS PHE ARG ASP PRO GLN MET CYS PHE ASP ILE CYS SEQRES 10 A 276 SER CYS GLN PHE VAL CYS HIS TYR SER PHE GLU SER TYR SEQRES 11 A 276 GLU GLN ALA ASP MET MET LEU ARG ASN ALA CYS GLU ARG SEQRES 12 A 276 LEU SER PRO GLY GLY TYR PHE ILE GLY THR THR PRO ASN SEQRES 13 A 276 SER PHE GLU LEU ILE ARG ARG LEU GLU ALA SER GLU THR SEQRES 14 A 276 GLU SER PHE GLY ASN GLU ILE TYR THR VAL LYS PHE GLN SEQRES 15 A 276 LYS LYS GLY ASP TYR PRO LEU PHE GLY CYS LYS TYR ASP SEQRES 16 A 276 PHE ASN LEU GLU GLY VAL VAL ASP VAL PRO GLU PHE LEU SEQRES 17 A 276 VAL TYR PHE PRO LEU LEU ASN GLU MET ALA LYS LYS TYR SEQRES 18 A 276 ASN MET LYS LEU VAL TYR LYS LYS THR PHE LEU GLU PHE SEQRES 19 A 276 TYR GLU GLU LYS ILE LYS ASN ASN GLU ASN LYS MET LEU SEQRES 20 A 276 LEU LYS ARG MET GLY LEU GLY CYS LEU SER LYS SER GLU SEQRES 21 A 276 TRP GLU ALA THR SER ILE TYR LEU VAL PHE ALA PHE GLU SEQRES 22 A 276 LYS GLN GLN SEQRES 1 B 276 SER GLN SER ARG ILE PHE TYR LEU ARG ASN PHE ASN ASN SEQRES 2 B 276 TRP MET LYS SER VAL LEU ILE GLY GLU PHE LEU GLU LYS SEQRES 3 B 276 VAL ARG GLN LYS LYS LYS ARG ASP ILE THR VAL LEU ASP SEQRES 4 B 276 LEU GLY CYS GLY LYS GLY GLY ASP LEU LEU LYS TRP LYS SEQRES 5 B 276 LYS GLY ARG ILE ASN LYS LEU VAL CYS THR ASP ILE ALA SEQRES 6 B 276 ASP VAL SER VAL LYS GLN CYS GLN GLN ARG TYR GLU ASP SEQRES 7 B 276 MET LYS ASN ARG ARG ASP SER GLU TYR ILE PHE SER ALA SEQRES 8 B 276 GLU PHE ILE THR ALA ASP SER SER LYS GLU LEU LEU ILE SEQRES 9 B 276 ASP LYS PHE ARG ASP PRO GLN MET CYS PHE ASP ILE CYS SEQRES 10 B 276 SER CYS GLN PHE VAL CYS HIS TYR SER PHE GLU SER TYR SEQRES 11 B 276 GLU GLN ALA ASP MET MET LEU ARG ASN ALA CYS GLU ARG SEQRES 12 B 276 LEU SER PRO GLY GLY TYR PHE ILE GLY THR THR PRO ASN SEQRES 13 B 276 SER PHE GLU LEU ILE ARG ARG LEU GLU ALA SER GLU THR SEQRES 14 B 276 GLU SER PHE GLY ASN GLU ILE TYR THR VAL LYS PHE GLN SEQRES 15 B 276 LYS LYS GLY ASP TYR PRO LEU PHE GLY CYS LYS TYR ASP SEQRES 16 B 276 PHE ASN LEU GLU GLY VAL VAL ASP VAL PRO GLU PHE LEU SEQRES 17 B 276 VAL TYR PHE PRO LEU LEU ASN GLU MET ALA LYS LYS TYR SEQRES 18 B 276 ASN MET LYS LEU VAL TYR LYS LYS THR PHE LEU GLU PHE SEQRES 19 B 276 TYR GLU GLU LYS ILE LYS ASN ASN GLU ASN LYS MET LEU SEQRES 20 B 276 LEU LYS ARG MET GLY LEU GLY CYS LEU SER LYS SER GLU SEQRES 21 B 276 TRP GLU ALA THR SER ILE TYR LEU VAL PHE ALA PHE GLU SEQRES 22 B 276 LYS GLN GLN HET SAH A 501 26 HET O94 A 502 26 HET SO4 A 503 5 HET GOL A 504 6 HET GOL A 505 6 HET SAH B 501 26 HET O94 B 502 26 HET SO4 B 503 5 HET SO4 B 504 5 HETNAM SAH S-ADENOSYL-L-HOMOCYSTEINE HETNAM O94 2-(4-FLUOROPHENYL)-1-[(3~{S})-3-(6-OXIDANYL-1~{H}- HETNAM 2 O94 PYRAZOLO[3,4-B]PYRIDIN-3-YL)PIPERIDIN-1-YL]ETHANONE HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 SAH 2(C14 H20 N6 O5 S) FORMUL 4 O94 2(C19 H19 F N4 O2) FORMUL 5 SO4 3(O4 S 2-) FORMUL 6 GOL 2(C3 H8 O3) FORMUL 12 HOH *108(H2 O) HELIX 1 AA1 ARG A 168 LYS A 195 1 28 HELIX 2 AA2 ASP A 211 GLY A 218 1 8 HELIX 3 AA3 ALA A 229 ASN A 245 1 17 HELIX 4 AA4 LEU A 266 LYS A 270 5 5 HELIX 5 AA5 VAL A 286 GLU A 292 5 7 HELIX 6 AA6 SER A 293 GLU A 306 1 14 HELIX 7 AA7 ASN A 320 ALA A 330 1 11 HELIX 8 AA8 TYR A 374 LYS A 384 1 11 HELIX 9 AA9 PHE A 395 ASN A 405 1 11 HELIX 10 AB1 ASN A 405 MET A 415 1 11 HELIX 11 AB2 SER A 457 SER A 465 1 9 HELIX 12 AB3 TYR B 171 LYS B 195 1 25 HELIX 13 AB4 ASP B 211 GLY B 218 1 8 HELIX 14 AB5 ALA B 229 ARG B 246 1 18 HELIX 15 AB6 LEU B 266 LYS B 270 5 5 HELIX 16 AB7 VAL B 286 PHE B 291 5 6 HELIX 17 AB8 SER B 293 GLU B 306 1 14 HELIX 18 AB9 ASN B 320 SER B 331 1 12 HELIX 19 AC1 TYR B 374 LYS B 383 1 10 HELIX 20 AC2 PHE B 395 LYS B 404 1 10 HELIX 21 AC3 ASN B 405 MET B 415 1 11 HELIX 22 AC4 SER B 457 SER B 465 1 9 SHEET 1 AA1 7 SER A 254 THR A 259 0 SHEET 2 AA1 7 LYS A 222 ASP A 227 1 N LEU A 223 O SER A 254 SHEET 3 AA1 7 THR A 200 LEU A 204 1 N ASP A 203 O VAL A 224 SHEET 4 AA1 7 PHE A 278 GLN A 284 1 O SER A 282 N LEU A 202 SHEET 5 AA1 7 LEU A 308 PRO A 319 1 O SER A 309 N PHE A 278 SHEET 6 AA1 7 TYR A 467 LYS A 474 -1 O PHE A 472 N PHE A 314 SHEET 7 AA1 7 MET A 387 THR A 394 -1 N VAL A 390 O ALA A 471 SHEET 1 AA2 4 SER A 335 GLY A 337 0 SHEET 2 AA2 4 TYR A 341 PHE A 345 -1 O VAL A 343 N PHE A 336 SHEET 3 AA2 4 LYS A 357 LEU A 362 -1 O ASP A 359 N LYS A 344 SHEET 4 AA2 4 VAL A 366 PHE A 371 -1 O VAL A 366 N LEU A 362 SHEET 1 AA3 7 SER B 254 THR B 259 0 SHEET 2 AA3 7 LYS B 222 ASP B 227 1 N CYS B 225 O GLU B 256 SHEET 3 AA3 7 THR B 200 LEU B 204 1 N ASP B 203 O VAL B 224 SHEET 4 AA3 7 PHE B 278 GLN B 284 1 O ASP B 279 N THR B 200 SHEET 5 AA3 7 LEU B 308 PRO B 319 1 O SER B 309 N PHE B 278 SHEET 6 AA3 7 TYR B 467 LYS B 474 -1 O PHE B 472 N PHE B 314 SHEET 7 AA3 7 MET B 387 THR B 394 -1 N VAL B 390 O ALA B 471 SHEET 1 AA4 4 SER B 335 GLY B 337 0 SHEET 2 AA4 4 TYR B 341 PHE B 345 -1 O VAL B 343 N PHE B 336 SHEET 3 AA4 4 LYS B 357 LEU B 362 -1 O ASN B 361 N THR B 342 SHEET 4 AA4 4 VAL B 366 PHE B 371 -1 O VAL B 366 N LEU B 362 CISPEP 1 GLU B 363 GLY B 364 0 -5.56 CRYST1 39.977 84.336 81.990 90.00 96.88 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025014 0.000000 0.003018 0.00000 SCALE2 0.000000 0.011857 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012285 0.00000